<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Common Conditions in High-Risk Newborns</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\(', '\)']],
            displayMath: [['$$', '$$'], ['\[', '\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="baby-at-risk-introduction.html" class="nav-button"> 
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 66.6%;"></div> <!-- Set percentage dynamically -->
                        </div>
                       <span class="progress-text">Lecture 2 of 3</span> <!-- Update text -->
                    </div>
                    <a href="midwifery-context.html" class="nav-button"> 
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">Common Conditions in High-Risk Newborns</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                <!-- START: neonatal-hypoglycemia -->
                <section id="neonatal-hypoglycemia" class="content-section" aria-labelledby="section-heading-1">
                    <h2 id="section-heading-1" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">1. NEONATAL HYPOGLYCAEMIA</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Description</h3>
                        <p>An acquired metabolic disorder characterized by abnormally low blood sugar such that for term babies, glucose levels are below $2.0 \mathrm{mmols} / \mathrm{L}$. the variation of the cut off values is because normal term infant uses compensatory mechanisms and alternative fuels such as ketone bodies, lactate or fatty acids to replace glucose</p>

                        <h3 class="subsection-heading">PREDISPOSING FACTORS (NEONATES AT RISK)</h3>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Low birth weight:</b> This is because these babies have lower glycogen stores hence cannot mobilize enough glucose. Simultaneously, have immature hormonal and enzyme responses and sometimes cannot feed orally at an early stage</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Severely asphyxiated:</b> The low oxygen supply upsets the metabolism of carbohydrates hence excessive catabolism of glycogen, leading to exhaustion of the stores</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Idiopathic respiratory distress:</b> Due to inadequate oxygen supply hence exhaustion of the glycogen stores</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Severe jaundice:</b> toxicity of the high levels of unconjugated bilirubin inhibits feeding hence high use of glucose</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Intracranial injury:</b> due to inadequate oxygen supply</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Severe infection:</b> inhibition of feeding</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Hypothermia:</b> excessive use of glucose to produce heat for survival</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Uncontrolled maternal medical condition:</b> becoz the neonate's pancrease produces large amounts of insulin in the $1^{\text {st }}$ week as it was during intrauterine stage</span></li>
                        </ul>

                        <h3 class="subsection-heading">CLINICAL FEATURES OF N. HYPOGLYCEMIA</h3>
                        <ol>
                            <li><b>Lethargy & poor feeding</b>- due to inadequate glucose supply to the tissues</li>
                            <li><b>Abnormal respiratory pattern</b>- characterized by episodes of shallow breathing and apnoea which finally leads to cyanosis as condition deteriorates. All this is due to reduced oxygen and glucose supply to the brain cells</li>
                            <li><b>Hypotonicity (limpness) & hypothermia</b>; becoz of insufficient supply of O2 & glucose to the muscles</li>
                            <li><b>Irritability</b>: which ranges from jitteriness( extreme nervousness & anxiety), later twitching- angles of mouth & eyes as well as extremeties and eventually seizures/convulsions. It is brought about by neuroglycopenia (insufficient to reduce glucose supply in the nerve cell)- intracranial haemorrhage</li>
                            <li><b>Coma</b>- it is a life threatening feature characterized by lack of sensation, abnormal heart & lungs function. Occurs due to either delay or omission of appropriate measures. Death occurs within 24 hrs if condition is neglected</li>
                        </ol>

                        <h3 class="subsection-heading">DIAGNOSTIC FACTORS</h3>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Hx</b>- of maternal diabetes, either gestational or chronic diabetes.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Physical examination findings</b>- features of irritability, limpness, lethargy e.t.c</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Lab tests</b>-Abnormal lab results e.g. low blood sugars e.t.c.</span></li>
                        </ul>

                        <h3 class="subsection-heading">SPECIFIC MANAGEMENT- N. HYPOGLYCEMIA</h3>
                        <p><b>PRINCIPLES OF MANAGEMENT:</b></p>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Adequate temperature control- keep the neonate warm</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Encourage early feeding- should be fed within 1 hour after delivery</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Encourage frequent feeding, at least every 3 hourly</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Blood glucose should be checked immediately before the second feed and then 4-6 hrly.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Observe high standards of hygiene to prevent infections.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Inform the DR concerning the condition</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Admit the baby in the NBU and manage as follows:</span></li>
                        </ul>

                        <h4 class="subsubsection-heading">If the Blood glucose less than $1.1 \mathrm{Mmol} / \mathrm{L}$;</h4>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Give a bolus of $2 \mathrm{ml} / \mathrm{kg}$ body weight of $10 \%$ glucose IV slowly over five minutes</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">If an IV line cannot be established quickly, give $2 \mathrm{ml} / \mathrm{kg}$ body weight of 10% glucose by Nasogastric tube</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Infuse $10 \%$ glucose at the daily maintenance volume according to the baby's age</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Assess the blood glucose 30 minutes after the bolus of glucose administration &;
                                <ul style="margin-top: 0.8rem;">
                                    <li>If the blood glucose is less than $1.1 \mathrm{mmol} / \mathrm{L}$, repeat the bolus of glucose (above) and continue the infusion then assess blood glucose again after 30 minutes</li>
                                    <li>If the blood glucose is between $1.1 \mathrm{mmol} / \mathrm{L}$ and $2.6 \mathrm{mmol} / \mathrm{L}$, continue the infusion and repeat the blood glucose testing every three hours until the blood glucose is $2.6 \mathrm{mmol} / \mathrm{L}$ or more on two consecutive tests</li>
                                </ul>
                            </span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Allow the baby to breastfeed.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">As the baby's ability to feed improves, slowly decrease (over a three-day period) the volume of IV glucose while increasing the volume of oral feeds.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Do not discontinue the glucose infusion abruptly</span></li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">If the Blood glucose is between 1.1-2.6 Mmol/L;</h4>
                        <ul class="enhanced-list">
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">If the blood glucose is between $1.1 \mathrm{mmol} / \mathrm{L}$ and $2.6 \mathrm{mmol} / \mathrm{L}$, allow the baby to breastfeed and repeat the blood glucose testing every three hours until the blood glucose is $2.6 \mathrm{mmol} / \mathrm{L}$ or more on two consecutive tests</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Once the blood glucose is $2.6 \mathrm{mmol} / \mathrm{L}$ or more for two consecutive tests;
                                <ul style="margin-top: 0.8rem;">
                                    <li>If the baby cannot breastfeed, give expressed breast milk using an alternative feeding method</li>
                                </ul>
                            </span></li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">Frequency of blood glucose measurements after blood glucose returns to normal</h4>
                        <ul class="enhanced-list">
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">If the baby is receiving IV fluid for any reason, continue blood glucose testing every 12 hours for as long as the baby requires IV fluid.</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">If the blood glucose is less than $2.6 \mathrm{mmol} / \mathrm{L}$ treat as described above</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">If the baby no longer requires or is not receiving IV fluid, assess blood glucose every 12 hours for 24 hours (two more tests):
                                <ul style="margin-top: 0.8rem;">
                                     <li>If the blood glucose remains normal, discontinue testing</li>
                                </ul>
                            </span></li>
                        </ul>
                        
                        <h3 class="subsection-heading">PROGNOSIS</h3>
                        <ul class="enhanced-list">
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Good:</b> with early diagnosis & immediate + proper mgt</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Poor/fatal</b> or leads to high morbidity rate, where the infant is a light or small for gestational age & proper mgt is delayed, becoz there's already some degree of cerebral damage= death or severe mental retardation and other associated conditions</span></li>
                        </ul>

                        <h3 class="subsection-heading">PREVENTION</h3>
                        <ol>
                            <li>Routine screening of the prenatals in order to identify the risk factors</li>
                            <li>Adequate temperature control at birth and thereafter( keep infant warm to prevent hypothermia)</li>
                            <li>Early feeding- using milk within $1^{\text {st }} 1$ hour for normal neonates and within 15 minutes of birth for those whose mother is diabetic. The milk has got fat content which spares enough glucose required for the normal cerebral functions hence less chances of brain damage</li>
                            <li>Frequent feeding thereafter atleast 3 hourly to maintain glucose concentration in the circulation hence normal body function</li>
                            <li>Accurate screening & follow-up of the neonates whose mothers are diabetic during the $1^{\text {st }}$ one week of birth</li>
                        </ol>
                    </div>
                </section>
                <!-- END: neonatal-hypoglycemia -->

                <!-- START: hyperglycemia -->
                <section id="hyperglycemia" class="content-section" aria-labelledby="section-heading-2">
                    <h2 id="section-heading-2" class="section-heading">
                        <span class="heading-icon"> </span>
                        <span class="heading-text">2. HYPERGLYCAEMIA</span>
                    </h2>
                    <div class="content-card">
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Definition:</b> Hyperglycemia is a serum glucose concentration > 8.3 $\mathrm{mmol} / \mathrm{L}$).</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">The most common cause of neonatal hyperglycemia is <b>Iatrogenic</b>.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Iatrogenic causes usually involve too-rapid IV infusions of dextrose during the first few days of life in very low-birth-weight infants (< 1.5 kg)</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Hyperglycaemia is much less of a clinical problem than hypoglycaemia & mostly occurs in pre-terms & severely growth restricted infants</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Symptoms and signs are those of the underlying disorder;</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Diagnosis is by serum glucose testing.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Additional laboratory findings may include glycosuria and marked serum hyperosmolarity.</span></li>
                        </ul>
                    </div>
                </section>
                <!-- END: hyperglycemia -->

                <!-- START: neonatal-jaundice -->
                <section id="neonatal-jaundice" class="content-section" aria-labelledby="section-heading-3">
                    <h2 id="section-heading-3" class="section-heading">
                        <span class="heading-icon"> </span>
                        <span class="heading-text">Neonatal jaundice</span>
                    </h2>
                    <div class="content-card">
                        <p>Jaundice is the yellow discoloration of skin & mucous membranes as a result of raised bilirubin levels(hyperbilirubinemia), occurring in the first 28 days of life.</p>
                        <p><b>Classification:</b> Physiological jaundice or Pathological jaundice</p>
                        <p>Visible form of bilirubinemia on;-</p>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Adult sclera >2 mg.dl</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Newborn skin >5 mg/dl</span></li>
                        </ul>
                        <p>Occurs in 60% of term & 80% of preterm neonates</p>
                        
                        <h3 class="subsection-heading">Bilirubin Physiology</h3>
                        <p>Source of production : Ageing, immature or malformed red cells are removed from the circulation & broken down in the reticuloendothelial system (liver, spleen & macrophages). Hemoglobin from these cells is broken down to the by-products of haem, globin & iron</p>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Heam is converted to biliverdin & then to unconjugated bilirubin</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Globin is broken down into amino acids, which are used by the body to make proteins</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Iron is stored in the body or used for new red cells</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">$3 / 4$ of bilirubin comes from hemoglobin catabolism.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">1 gm of hemoglobin results in the production of 34 mg of bilirubin.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">A normal term new born produces about $6-10 \mathrm{mg} / \mathrm{kg} /$ day</span></li>
                        </ul>
                        <p>Three stages are involved in the process of bilirubin conjugation; a)Transport, b)Conjugation & c)Excretion</p>
                        <img src="../assets/images/2025_08_31_35321b895bc9b415cdfbg-066-1.jpg" alt="Diagram illustrating the physiology of bilirubin, showing its production from hemoglobin, transport in the blood, conjugation in the liver, and excretion." class="content-image">
                        
                        <h4 class="subsubsection-heading">a) Transportation of bilirubin</h4>
                        <p>Unconjugated or fat soluble bilirubin is transported to the liver bound to albumin. If not attached to albumin, this unbound or 'free' bilirubin can be deposited in extravascular fatty & nerve tissues (skin & brain). Skin deposits of unconjugated or fat soluble bilirubin causes jaundice, while brain deposits can cause bilirubin toxicity or kernicterus</p>
                        <p>Once in the liver, unconjugated bilirubin is detached from albumin, combined with glucose & glucoronic acid & conjugation occurs in the presence of oxygen & the enzyme Uridine diphosphoglucoronyl transferase (UDP-GT). The conjugated bilirubin is now water soluble & available for excretion</p>

                        <h4 class="subsubsection-heading">c) Excretion</h4>
                        <p>Conjugated bilirubin is excreted via the biliary system into the small intestine where normal bacteria change the conjugated bilirubin into urobilinogen. This is then oxidized into orange colored urobilin. Most is excreted in the feaces, with a small amount excreted in urine</p>
                        <p>Two main forms of bilirubin are present in the body;</p>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Unconjugated bilirubin</b> is fat soluble & cannot be excreted easily either in bile or urine. Neonatal jaundice can result from increased levels of this fat soluble bilirubin that cannot be excreted and is instead deposited in fatty tissue</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Conjugated bilirubin</b> has been made water soluble in the liver & can be excreted in feces & urine. Neonatal jaundice can also result from increased levels of this water soluble bilirubin if excretion is prevented, e.g. by an obstruction</span></li>
                        </ul>

                        <h3 class="subsection-heading">Assessment of jaundice</h3>
                        <p>Clinical jaundice first becomes obvious in the face followed by a downward progression as it increases in intensity. Assessment of jaundice should be done in natural light. The finger is pressed on the baby's skin, preferably over a bony part, till it blanches. The underlying skin is noted for yellow color. Confirm bilirubin level by lab</p>

                        <h3 class="subsection-heading">a) Physiological jaundice</h3>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Also known as icterus neonatorum</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Neonatal physiological jaundice occurs when unconjugated (fat soluble) bilirubin is deposited in the skin instead of being taken to the liver for processing into conjugated (water soluble) bilirubin that can be excreted in feces or urine.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">It is a normal transitional state affecting up to 60% of term & 80% of premature babies who have a progressive rise in unconjugated bilirubin level & jaundice on day 3.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Physiological jaundice never appears before 24 hours of life, usually fades by 1 week of age & bilirubin levels don't exceed $12-13 \mathrm{mg} / \mathrm{dL}$ (200-215 umol/L).</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Lasts 5th to 7th day</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Managed with phototherapy if levels rise significantly >5 mg/dl/day</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">In many newborns a temporary discrepancy exists between red cells breakdown and their ability to transport, conjugate & excrete the resulting bilirubin.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Physiological jaundice results from increased red cell breakdown at a time of newborn immaturity</span></li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">Why does physiological Jaundice develop?</h4>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Increased bilirubin load (incres RBC brkdwn)</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Decreased trasport of bilirubin to the liver (deficient albumin)</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Defective conjugation (reduced levels of UDP-GT enzyme levels)</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Decreased excretion</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Increased entero-hepatic reabsorption</span></li>
                        </ul>

                        <h4 class="subsubsection-heading">Characteristic of physiological jaundice</h4>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Appears after 24 hours</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Maximum intensity seen on 4-5th day in term & 7th day in preterm neonates</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Mainly occurs in the skin & eyes</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Baby looks & feeds well</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Serum levels do not exceed $15 \mathrm{mg} / \mathrm{dl}$</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Clinically undetectable after 14 days</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Disappears without any treatment</span></li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">Management of physiological jaundice.</h4>
                        <ul class="enhanced-list">
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">No treatment is required but baby should be observed closely for signs of worsening jaundice</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Early frequent breast feeding - breast feeding ensures glucose supply to the liver, increases bowel motility & normal bowel flora.</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Associated with decreased milk intake related to fewer calories consumed by infant before mother's milk is well established</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Mother advised to expose the baby in the sunlight</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Phototherapy</span></li>
                        </ul>

                        <h3 class="subsection-heading">Pathological jaundice</h3>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Pathological jaundice in newborns usually appears within 24 hours of birth.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Increase of serum bilirubin> $5 \mathrm{mg} / \mathrm{dl} /$ day</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Serum bilirubin $>15 \mathrm{mg} / \mathrm{dl}$</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Clinical jaundice is persistent after 14 days</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Stool clay/ white colored or urine staining clothes</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Direct bilirubin $>2 \mathrm{mg} / \mathrm{dl}$ at any time</span></li>
                        </ul>

                        <h4 class="subsubsection-heading">causes</h4>
                        <p><b>Appearing within 24 hours of age</b></p>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Hemolytic disease of the newborn; Rh, ABO incompartibilities</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Infections: TORCH, malaria, bacterial</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Enzyme deficiencies - (G6PD deficiency leads to increased hemolysis of RBCs)</span></li>
                        </ul>
                        <p><b>Appearing between 24-72 hours of life</b></p>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Physiological</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Sepsis neonatorum</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Polycythemia</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Concealed hemorrhage: cephalhematoma, SAH, IVH</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Increased enterohepatic circulation</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Drugs that compete with bilirubin for albumin binding sites e.g. asprin, ampicillin, sulphonamides</span></li>
                        </ul>

                        <h3 class="subsection-heading">diagnosis</h3>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Review the maternal & perinatal hx</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Family hx of jaundice</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Previous siblings with jaundice</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Maternal illness during pregnancy</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Hx of malaria traumatic delivery, delayed cord clamping</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Physical examination</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Laboratory tests</b>
                                <ul style="margin-top: 0.8rem;">
                                    <li>Total & direct bilirubin</li>
                                    <li>Blood group & Rh for mother & baby</li>
                                    <li>Hematocrit</li>
                                    <li>Direct Coomb's test on infant</li>
                                    <li>Septic screen</li>
                                    <li>Liver & thyroid function tests</li>
                                </ul>
                            </span></li>
                        </ul>

                        <h3 class="subsection-heading">management</h3>
                        <p>Rationale: reduce level of serum bilirubin & prevent bilirubin CNS toxicity</p>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Keep baby warm</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Continue breastfeeding or give EBM</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Administer antibiotics when indicated</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Prevention of hyperbilirubinemia:</b> Early feeding, Adequate hydration</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Reduction of bilirubin:</b> Phototherapy, Exchange transfusion, Natural light (leads to hyperthermia commonly)</span></li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">phototherapy</h4>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Is the primary treatment for unconjugated hyperbilirubinemia</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">This involves exposure of the naked baby to blue, cool white or green light of wavelength $450-460 \mathrm{~nm}$.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">The light waves convert the bilirubin to water soluble nontoxic forms which are then easily excreted.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Reduces the risk of bilirubin-induced neurotoxicity, because watersoluble photoisomers do not cross the BBB</span></li>
                        </ul>
                        <div class="equation">Bilirubin 450-460nm Photoisomers of Bilirubin</div>
                        <p>(Insoluble) Light (Soluble</p>

                        <h4 class="subsubsection-heading">phototherapy procedure</h4>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Place baby naked in an incubator/ cot</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">External genitalia may be covered while giving phototherapy</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Fix eye shields</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">The energy delivered to the infant's skin decreases with increasing distance between the infant & the light source.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Baby placed at 45 cm from light</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">3 hourly feeding must be continued</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Turn baby 2 hourly or after every feed</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Monitor temp 2-4 hourly</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Weigh the baby on alternate days</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Monitor serum bilirubin daily</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Discontinue phototherapy if the serum bilirubin values are <10 mg/d</span></li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">Side effects of phototherapy</h4>
                        <ul class="enhanced-list">
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Hyperthermia</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Increased fluid loss</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Dehydration</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Damage to the retina by the high light intensity</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Lethargy or irritability</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Loose stools</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Skin rashes/ skin burns</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Increased insensible water loss: provide more frequent extra breast feeding</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Isolation & lack of usual sensory experiences, including visual deprivation</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">A decrease in calcium levels leading to hypocalcemia</span></li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">Care during phototherapy</h4>
                        <ul class="enhanced-list">
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Monitor baby's temperature</b> - observe for hypothermia/ hyperthermia</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Eyes</b> - shields or patches must cover the eyes without occluding the nose, & not be too tight or cause eye discharge or weeping</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Skin</b> - cleaned with warm water & observed for rashes, dryness & excoriation</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Position</b> under phototherapy to expose all body surface areas to the light</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Weigh</b> the infant daily</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Monitor</b> fluid administration, urine output</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Hydration</b> - fluid intake & output are monitored & feeding is continued. Consider IVF for ill or dehydrated babies</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Neurobehavioral states</b> - need for interaction with nurse, parents & other caregivers</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Monitor calcium levels</b> - symptoms for hypocalcemia include; jitteriness, irritability, rash, loose stools, fever, dehydration & convulsions (common in preterm babies)</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Parent support</b></span></li>
                        </ul>

                        <h3 class="subsection-heading">Exchange transfusion</h3>
                        <p><b>Indications:</b></p>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">If intensive phototherapy has failed to reduce bilirubin levels to a safe range</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">The infant has signs of kernicterus (lethargy, decreased feeding, hypotonia, a high-pitched cry, opisthotonous, setting sun sign, fever, seizures)</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Signs of congestive cardiac failure</span></li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">Complications of jaundice</h4>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text"><b>Kernicterus</b> - bilirubin brain damage. Identified by;
                                <ul style="margin-top: 0.8rem;">
                                    <li>lethargy & poor feeding</li>
                                    <li>poor or absent moro reflex</li>
                                    <li>Opisthotonous</li>
                                    <li>convulsions</li>
                                </ul>
                            </span></li>
                        </ul>
                    </div>
                </section>
                <!-- END: neonatal-jaundice -->

                <!-- START: abo-rhesus-incompatibility -->
                <section id="abo-rhesus-incompatibility" class="content-section" aria-labelledby="section-heading-4">
                    <h2 id="section-heading-4" class="section-heading">
                        <span class="heading-icon"> </span>
                        <span class="heading-text">ABO and Rhesus Incompatibility</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">ABO incompatibility</h3>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">ABO Incompatibility can occur if the mother and the baby have different blood types.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">when the mother has type O blood and the baby has type A, B, or AB blood.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">People with type O blood produce anti-A and anti-B antibodies.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Individuals with type O blood develop antibodies throughout life from exposure to nutrition, diet, some infections & transfusions</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">The anti-A and anti-B antibodies formed are igG antibodies</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">igG can cross the placenta and attach to fetal red cells and destroy them</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">When a type O blood mom is pregnant with a type A, B, or AB blood baby, there is a chance that the anti-A or anti-B antibodies will pass through the placenta during pregnancy or birth and cause ABO Incompatibility.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Like the antibodies produced in Rh Disease, the antibodies with ABO incompatibility attack the baby's red blood cells once they pass through the placenta.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">These antibodies can cause the rapid breakdown of the baby's red blood cells.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Bilirubin is produced when the body breaks down red blood cells and this rapid breakdown of the baby's red blood cells causes a quick build up of bilirubin, resulting in jaundice and sometimes anemia.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Diagnosis is done by direct coombs test to identify maternal antibodies on foetal RBCs</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">ABO usually causes mild haemolysis</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Management depends on the degree of jaundice</span></li>
                        </ul>

                        <h3 class="subsection-heading">Rhesus Isoimmunisation</h3>
                        <p>Also called RhD incompatibility. The D antigen is found on RBCs. RBCs with antigen D are rhesus positive, while RBCs without antigen D are rhesus negative.</p>
                        <p>Rhesus disease occur when a woman with Rh-negative blood is pregnant with Rh positive fetus. It does not affect a first pregnancy. The mother must have exposure to Rh-positive fetal cells in a previous pregnancy, then she develops antibodies against the rhesus antigen. The ig G antibodies can cross from the mother to the fetus through the plcenta</p>
                        <img src="../assets/images/2025_08_31_35321b895bc9b415cdfbg-109-1.jpg" alt="Diagram illustrating Rh-Isoimmunization. It shows an Rh-negative mother with an Rh-positive fetus, leading to the mother developing anti-D antibodies which can affect subsequent Rh-positive pregnancies." class="content-image">

                        <h4 class="subsubsection-heading">Events that facilitate rhesus disease</h4>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Miscarriage</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Termination of pregnancy (abortion)</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">APH</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Invasive prenatal testing e.g. amniocentesis , cordocentesis,chorionic villus sampling,fetal blood sampling</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">delivery</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Ectopic pregnancy</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">External cephalic version</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Fetal death in utero or stillbirth</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Abdominal trauma</span></li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">Prevention of Rhesus disease</h4>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Screening women for the rhesus factor and antibodies</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Administration of anti-D immunoglobulins to non-sensitized women within 72 hours of birth or any other sensitizing event</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Anti-D ig destroys any fetal cells in the mothers blood before her immune system produces antibodies</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Where feasible, administration of anti-D at 28 & 34 weeks gestation is recommended</span></li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">Effects of Rh D isoimmunization</h4>
                        <ul class="enhanced-list">
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Destruction of fetal RBCs (hemolytic anemia)</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Oedema</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Congestive Cardiac failure</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Jaundice with kernicterus</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Haemorrhagic disease of the newborn</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Hydrops fetalis due to excessive haemolysis</span></li>
                        </ul>

                        <h4 class="subsubsection-heading">Management of RhD isoimmunization</h4>
                        <ul class="enhanced-list">
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Exchange blood transfusion</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Phototherapy to reduce bilirubin levels</span></li>
                        </ul>
                    </div>
                </section>
                <!-- END: abo-rhesus-incompatibility -->
                
                <!-- START: maternal-drug-abuse -->
                <section id="maternal-drug-abuse" class="content-section" aria-labelledby="section-heading-5">
                    <h2 id="section-heading-5" class="section-heading">
                        <span class="heading-icon"> </span>
                        <span class="heading-text">EFFECTS OF MATERNAL DRUG ABUSE/USE DURING PREGNANCY ON THE NEWBORN</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">DESCRIPTION:</h3>
                        <p>The incidence of drug use within the population has a large geographical variation. As a result, the incidence of drug withdrawal symptoms among neonates & infants also has a high incidence. Opiates & other drugs cross the placenta & the fetus during pregnancy is likely to be exposed to the same peaks & troughs of drug exposure that the mother is. Withdrawal may be manifested b4 birth</p>
                        <aside class="callout note" role="note">
                             <h4 class="callout-title"><span class="callout-icon"> </span>ASSIGNMENT</h4>
                             <p>Pharmacological drugs that can easily cross the placenta barrier & their effects on the fetus.</p>
                        </aside>
                        <p>Infants born to mothers who have used illicit drugs during pregnancy are at risk of withdrawal symptoms. The common substances abused by pregnant women are CNS depressants (alcohol, sedatives), Stimulants (cocaine, amphetamines), Opiates & narcotics, and Hallucinogens.</p>
                        <p>The effects of substance abuse during pregnancy may be classified into three categories:</p>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Effects of the illicit substance(s) on the mother</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Effects on the course of pregnancy and delivery</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Effects on the fetus, newborn, and developing child</span></li>
                        </ul>
                        
                        <h3 class="subsection-heading">Neonatal effects of substance abuse:</h3>
                        <p>NB// These depend on the specific substance abused by the mother but generally include:</p>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">congenital anomalies</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">neonatal medical complications such as sudden infant death syndrome (SIDS), neonatal abstinence syndrome (NAS), and respiratory distress syndrome.</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Neurobehavioral changes</span></li>
                        </ul>

                        <h3 class="subsection-heading">What is neonatal abstinence syndrome (NAS)?</h3>
                        <p>Refers to a group of problems that occur in a newborn who was exposed to addictive opiate & narcotic drugs in utero. These substances cross the placenta barrier and the fetus becomes addicted along with the mother. This disorder may be associated with long term problems to the baby.</p>

                        <h4 class="subsubsection-heading">CLINICAL FEATURES OF NEONATAL DRUG WITHDRAWAL</h4>
                        <p>These symptoms usually begin 1-3 days after birth but may take up to a week to appear. The withdrawal symptoms most frequently seen in neonates are:</p>
                        <ul class="enhanced-list">
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Jitteriness/ restlessness</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Tremor & Irritability</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Constant/persistent high pitched crying</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Infants often fail to settle btwn feeds (disorganized sucking)</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Hyperactivity</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Frequent yawning (irrespective of adequate periods of feeding), sneezing & vomiting</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Sweating, pyrexia (may also be in the absence of an infection) & convulsions</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Respiratory distress</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Diarrhoea & an irritant nappy rash</span></li>
                            <li class="list-item"><span class="item-icon">•</span><span class="item-text">Episodes of high temp in the absence of an infection</span></li>
                        </ul>
                        
                        <h4 class="subsubsection-heading">SPECIFIC MGT OF NEONATAL ABSTINENCE SYNDROME:</h4>
                        <p>Divided into general care given to these infants & pharmacological rx</p>
                        <ul class="enhanced-list">
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Keep the infant with the mother to enhance bonding</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Encourage breastfeeding as long as there's no evidence of HIV or ongoing drug use by the mother esp. cocaine and heroine</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">A quiet envt with reduced light and noise is helpful in keeping stimuli to a minimum</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Feeds should be given frequently</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Build up a good working relationship with the mother</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Communication should be clear and non judgmental</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Explain the baby's presenting signs and emphasize that the behavior is not a rejection of their parents</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Encourage parents to take active part in the care of their baby</span></li>
                             <li class="list-item"><span class="item-icon">•</span><span class="item-text">Emphasize the possible effects of breast feeding, which would be harmful especially with cocaine and heroine.</span></li>
                        </ul>
                    </div>
                </section>
                <!-- END: maternal-drug-abuse -->
            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="baby-at-risk-introduction.html" class="nav-button"> 
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 66.6%;"></div> <!-- Set percentage dynamically -->
                        </div>
                       <span class="progress-text">Lecture 2 of 3</span> <!-- Update text -->
                    </div>
                    <a href="midwifery-context.html" class="nav-button"> 
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script> <!-- Basic JS for disabled links etc. -->
</body>
</html>